We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
OP15.03: Maternal cardiovascular hemodynamics for the prediction of pre‐eclampsia at 12–16 weeks.
- Authors
Wang, X.; Chen, Y.; Sahota, D.S.; Tai, S.; Liu, F.; Wong, L.; Liu, J.; Lau, S.; Hoang, L. Nguyen; Lee, A.; Poon, L.C.
- Abstract
This article, titled "Maternal cardiovascular hemodynamics for the prediction of pre-eclampsia at 12-16 weeks," examines the screening performance of maternal cardiovascular hemodynamic parameters in combination with the first trimester Fetal Medicine Foundation (FMF) triple test for preterm pre-eclampsia (PE) and any onset PE. The study involved a case-control analysis of 743 singleton pregnancies, with 39 cases developing PE. The results showed that women who develop PE tend to have increased systemic vascular resistance (SVR) and decreased stroke volume (SV) and cardiac output (CO) compared to those who do not develop PE. However, adding hemodynamic parameters to the FMF triple test did not enhance its screening performance for PE.
- Subjects
PLACENTAL growth factor; RECEIVER operating characteristic curves; VASCULAR resistance; HIGH-risk pregnancy; CARDIAC output
- Publication
Ultrasound in Obstetrics & Gynecology, 2024, Vol 64, p99
- ISSN
0960-7692
- Publication type
Article
- DOI
10.1002/uog.27994